Delivering on the Promise of Cannabinoids

Developing CBD therapeutics to FDA standards

ANANDA’s Nantheia™ Investigational Drugs are currently being evaluated in multiple FDA-approved clinical trials in PTSD, OUD, SAD and Pain.

Active R&D program focused on Developing New Formulations targeting new therapeutic indications, including rare diseases.

Grounded in Science, driven by innovation, we strive to make a meaningful impact on global healthcare